These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 31245055)

  • 1. Serious infection risk in rheumatoid arthritis compared with non-inflammatory rheumatic and musculoskeletal diseases: a US national cohort study.
    Mehta B; Pedro S; Ozen G; Kalil A; Wolfe F; Mikuls T; Michaud K
    RMD Open; 2019; 5(1):e000935. PubMed ID: 31245055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders.
    Wolfe F; Michaud K; Chakravarty EF
    Rheumatology (Oxford); 2006 Nov; 45(11):1370-5. PubMed ID: 17003175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases.
    Hasseli R; Mueller-Ladner U; Hoyer BF; Krause A; Lorenz HM; Pfeil A; Richter J; Schäfer M; Schmeiser T; Strangfeld A; Schulze-Koops H; Voll RE; Specker C; Regierer AC
    RMD Open; 2021 Jan; 7(1):. PubMed ID: 33479021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study.
    Pawar A; Desai RJ; Solomon DH; Santiago Ortiz AJ; Gale S; Bao M; Sarsour K; Schneeweiss S; Kim SC
    Ann Rheum Dis; 2019 Apr; 78(4):456-464. PubMed ID: 30679153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, risk factors and validation of the RABBIT score for serious infections in a cohort of 1557 patients with rheumatoid arthritis.
    Thomas K; Lazarini A; Kaltsonoudis E; Voulgari PV; Drosos AA; Repa A; Sali AMI; Sidiropoulos P; Tsatsani P; Gazi S; Evangelia A; Boki KA; Katsimbri P; Boumpas D; Fragkiadaki K; Tektonidou MG; Sfikakis PP; Karagianni K; Sakkas LI; Grika EP; Vlachoyiannopoulos PG; Evangelatos G; Iliopoulos A; Dimitroulas T; Garyfallos A; Melissaropoulos K; Georgiou P; Areti M; Georganas C; Vounotrypidis P; Georgiopoulos G; Kitas GD; Vassilopoulos D
    Rheumatology (Oxford); 2021 May; 60(5):2223-2230. PubMed ID: 33295627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serious infection across biologic-treated patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
    Rutherford AI; Subesinghe S; Hyrich KL; Galloway JB
    Ann Rheum Dis; 2018 Jun; 77(6):905-910. PubMed ID: 29592917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Subsequent Infection Among Patients Receiving Tumor Necrosis Factor Inhibitors and Other Disease-Modifying Antirheumatic Drugs.
    Accortt NA; Bonafede MM; Collier DH; Iles J; Curtis JR
    Arthritis Rheumatol; 2016 Jan; 68(1):67-76. PubMed ID: 26359948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten-year retrospective review of the incidence of serious infections in patients on biologic disease modifying agents for rheumatoid arthritis in three tertiary hospitals in Western Australia.
    Sharma C; Keen H
    Intern Med J; 2019 Apr; 49(4):519-525. PubMed ID: 30230146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between lymphopenia and serious infection risk in rheumatoid arthritis.
    Subesinghe S; Kleymann A; Rutherford AI; Bechman K; Norton S; Benjamin Galloway J
    Rheumatology (Oxford); 2020 Apr; 59(4):762-766. PubMed ID: 31504905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple morbidities are associated with serious infections in patients with rheumatoid arthritis.
    Kimbrough BA; Crowson CS; Lennon RJ; Davis JM; Strangfeld A; Myasoedova E
    Semin Arthritis Rheum; 2024 Apr; 65():152386. PubMed ID: 38244447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Sustained Remission on the Risk of Serious Infection in Patients With Rheumatoid Arthritis.
    Accortt NA; Lesperance T; Liu M; Rebello S; Trivedi M; Li Y; Curtis JR
    Arthritis Care Res (Hoboken); 2018 May; 70(5):679-684. PubMed ID: 28960869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent serious infections in patients with rheumatoid arthritis-results from the British Society for Rheumatology Biologics Register.
    Subesinghe S; Rutherford AI; Byng-Maddick R; Leanne Hyrich K; Benjamin Galloway J
    Rheumatology (Oxford); 2018 Apr; 57(4):651-655. PubMed ID: 29340619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis.
    Widdifield J; Bernatsky S; Paterson JM; Gunraj N; Thorne JC; Pope J; Cividino A; Bombardier C
    Arthritis Care Res (Hoboken); 2013 Mar; 65(3):353-61. PubMed ID: 22833532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of peripheral arterial occlusive disease in patients with rheumatoid arthritis. A nationwide population-based cohort study.
    Chuang YW; Yu MC; Lin CL; Yu TM; Shu KH; Huang ST; Kao CH
    Thromb Haemost; 2016 Jan; 115(2):439-45. PubMed ID: 26446613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Risk of Chronic Kidney Disease in Rheumatoid Arthritis Associated with Cardiovascular Complications - A National Population-Based Cohort Study.
    Chiu HY; Huang HL; Li CH; Chen HA; Yeh CL; Chiu SH; Lin WC; Cheng YP; Tsai TF; Ho SY
    PLoS One; 2015; 10(9):e0136508. PubMed ID: 26406879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry.
    van Dartel SA; Fransen J; Kievit W; Flendrie M; den Broeder AA; Visser H; Hartkamp A; van de Laar MA; van Riel PL
    Ann Rheum Dis; 2013 Jun; 72(6):895-900. PubMed ID: 22887849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-dependent increased risk for serious infection from continuous use of tumor necrosis factor antagonists over three years in patients with rheumatoid arthritis.
    Sakai R; Komano Y; Tanaka M; Nanki T; Koike R; Nagasawa H; Amano K; Nakajima A; Atsumi T; Koike T; Ihata A; Ishigatsubo Y; Saito K; Tanaka Y; Ito S; Sumida T; Tohma S; Tamura N; Fujii T; Sugihara T; Kawakami A; Hagino N; Ueki Y; Hashiramoto A; Nagasaka K; Miyasaka N; Harigai M;
    Arthritis Care Res (Hoboken); 2012 Aug; 64(8):1125-34. PubMed ID: 22422487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a risk score for serious infection in patients with rheumatoid arthritis.
    Crowson CS; Hoganson DD; Fitz-Gibbon PD; Matteson EL
    Arthritis Rheum; 2012 Sep; 64(9):2847-55. PubMed ID: 22576809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and severeness of COVID-19 hospitalization in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark.
    Cordtz R; Lindhardsen J; Soussi BG; Vela J; Uhrenholt L; Westermann R; Kristensen S; Nielsen H; Torp-Pedersen C; Dreyer L
    Rheumatology (Oxford); 2021 Oct; 60(SI):SI59-SI67. PubMed ID: 33369663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-typhi Salmonella infection in patients with rheumatic diseases on TNF-alpha antagonist therapy.
    Peña-Sagredo JL; Fariñas MC; Perez-Zafrilla B; Cruz-Valenciano A; Crespo M; Joven-Ibañez B; Riera E; Manero-Ruiz FJ; Chalmeta I; Hernández MV; Rodríguez-Gómez M; Maíz O; López R; Cobo T; Pita J; Carmona L; Gonzalez-Gay MA;
    Clin Exp Rheumatol; 2009; 27(6):920-5. PubMed ID: 20149306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.